Pacira BioSciences Announces Publication of Positive Two-Year Phase 1 Data For PCRX-201 in Annals of the Rheumatic Diseases

Phase 1positivePCRX-201Positive

AI Analysis

Summary

Pacira BioSciences announced publication of positive two-year Phase 1 data for PCRX-201 in the Annals of the Rheumatic Diseases. The data supports continued development of the candidate for rheumatic disease indications.

Clinical Trial Data

Phase

Phase 1

Primary Endpoint

Met

Outcome Details

Two-year Phase 1 data published in Annals of the Rheumatic Diseases

Importance:5/10

Sentiment:

0.65

Phase 1 dataPublicationRheumatic diseasesData readout

Related Companies

$PCRX

Read the original article

Published by yahoo_finance on August 6, 2026 12:00 PM

Read Original